百诚医药(301096.SZ)：控制的合伙企业拟认购私募基金份额

Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) aims to enhance capital utilization and achieve quality asset allocation by participating in the subscription of shares in West Lake Innovation (Hangzhou) Venture Capital Partnership [1] Group 1 - Baicheng Pharmaceutical plans to invest 15 million yuan through its controlled entity, Hangzhou Mipeng Enterprise Management Partnership [1] - The investment will focus on strategic emerging industries such as biomedicine and hard technology [1] - The partnership agreement was signed on September 19, 2025, indicating a long-term investment strategy [1]